MxT = Microfluidics x Therapy
Microfluidic Gene Editing for Cell Therapy Starts Right Here
We transform cancer immunotherapy, cellular engineering and genome editing with our patented non-viral genome editing technology, Hydroporator .
Contact info
#907, Ttukseom-ro 17ga-gil 48, Seongdong-gu, Seoul, 04785, Republic of Korea
02-2157-4808 contact@mxtbiotech.com